Greece is the birthplace of ancient Greek medicine.
And as it has been the subject of numerous scientific investigations, there is growing evidence that it has medicinal benefits for people suffering from various ailments.
But is there any evidence that these products have actually made a difference?
That’s what scientists and pharmaceutical companies want to find out.
“Greece is a very old country, and we know from the ancient Greeks that there were a lot of products, for example, from the Middle Ages, that were being used in ancient times, so we know that there was a lot,” says Dr. Mihail Cherebetski, the lead author of a study published by the journal PLOS ONE.
“But there are still some questions.
And the biggest one is, why are these products still being used today?”
“It’s difficult to answer that question because there is no evidence that they actually work.
They’re only being used to make medicines,” he adds.
In a study, researchers from the University of Athens, the University Of Tartu, the National Health and Medical Research Council, and the University College London looked at the composition of different Greek pharmaceuticals and concluded that they all contained the same compounds, or “compounds,” that they used in traditional medical practices.
These included anhydrous sodium chloride (ascorbic acid), which is found in a number of plants, and potassium chloride, which is a natural compound found in soil and in water.
The researchers also found that the compounds were chemically similar to one another, which makes them “very similar to the composition found in pharmaceuticals made from other ingredients,” says lead author Dr. Maria Piotrowska, a pharmacologist and research assistant professor at the University’s Department of Chemistry.
“The difference between the three products is that in the anhydric sodium chloride product, it contains less sodium, and in the potassium chloride product it contains more sodium,” says Piotrowkska.
The findings are important because they show that there are no obvious differences between these two products, meaning that they are safe to use, she adds.
“What we think is important is that this information is being used so that we can better understand what are the medicinal benefits of these products,” says Cherebski.
“And we can use this information to develop more effective products.”
The researchers are currently working on a project to analyze the composition and biological activities of the products.
But until now, there was no scientific study that compared the compositions of the different products.
“There’s a huge gap in our knowledge,” says co-author and research associate Professor Vytautas Goulardakis, the director of the Laboratory of Molecular Biology at the National University of Greece.
“So, we wanted to take this opportunity to investigate these products.”
This new study, conducted by a team of researchers from Athens, Tartu and the National Institutes of Health, is one of the first studies to analyze their compositions.
The team used molecular techniques and chemical analyses to compare the various products, which were tested for their effects on the body.
They also used immunoassay to assess whether the compounds would bind to specific receptors on human cells.
These tests were performed in mice that were given the compounds.
“In the first study, we found that sodium chloride has a powerful effect on human cell-surface receptors and is capable of activating them.
We also found a very strong affinity for the human receptor TRPV1,” says Goulardsakis.
“We used this affinity to identify TRP receptors in the human blood plasma, and found that they were involved in the response to sodium chloride,” he says.
The TRP receptor, which Goulsardsakis refers to as the “endocrine receptor,” is a key part of the body’s immune system, and is responsible for detecting and responding to different types of bacteria.
The scientists also found an association between the TRP protein and the anti-inflammatory properties of the anabolic steroid ephedrine.
“This study is a milestone in our quest to understand how these compounds interact with the body, and to develop new therapeutics that work on the basis of this receptor,” says Jana Moulkoulou, a professor of pharmacology at the Athens University and a co-senior author of the study.
In addition to these research findings, the team also performed experiments on mice to confirm their results.
They found that these compounds are capable of altering the activity of certain cellular processes, including the activation of the antiplatelet antibody, the antiherpetic antibody, and a protein called C-reactive protein.
This is important because it could help to develop a new class of drugs, which would be effective against certain types of infections, such as arthritis and psoriasis, the authors say.
“These compounds are important for many reasons, but the most important is the potential for them to help people,” says M